Friday, 16 October 2026European Markets

VERALLIA And TFF GROUP Have A High Dividend Yield And Return On Equity In The Packaging & Containers Industry.

Loading stream...

(vianews) - verallia (vrla.pa) is among this list of stock assets with the highest dividend rate and return on equity on the packaging & containers industry.

financial asset price forward dividend yield return on equity
verallia (vrla.pa) €30.84 4.57% 44.03%
tff group (tff.pa) €42.30 1.43% 12.23%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. verallia (vrla.pa)

4.57% forward dividend yield and 44.03% return on equity

verallia société anonyme produces and sells glass packaging products for beverages and food industry worldwide. it also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. the company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. verallia société anonyme was founded in 1827 and is based in courbevoie, france.

earnings per share

as for profitability, verallia has a trailing twelve months eps of €4.08.

pe ratio

verallia has a trailing twelve months price to earnings ratio of 7.56. meaning, the purchaser of the share is investing €7.56 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.03%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, verallia's stock is considered to be oversold (<=20).

volume

today's last reported volume for verallia is 29927 which is 80.59% below its average volume of 154208.

more news about verallia.

2. tff group (tff.pa)

1.43% forward dividend yield and 12.23% return on equity

tff group manufactures and distributes barrels and wood products for the aging of wines, spirits, and alcohols in france, rest of europe, oceania and south africa, the united states, and internationally. the company also offers staves, cooperages, casks, wood and oenological products, and stainless steel containers. it primarily serves wine, whisky, and bourbon markets. the company was formerly known as tonnellerie françois frères. tff group was founded in 1910 and is based in saint-romain, france.

earnings per share

as for profitability, tff group has a trailing twelve months eps of €2.44.

pe ratio

tff group has a trailing twelve months price to earnings ratio of 17.34. meaning, the purchaser of the share is investing €17.34 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.23%.

moving average

tff group's value is under its 50-day moving average of €42.31 and higher than its 200-day moving average of €41.26.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, tff group's stock is considered to be overbought (>=80).

volatility

tff group's last week, last month's, and last quarter's current intraday variation average was a positive 0.48%, a negative 0.09%, and a positive 1.08%.

tff group's highest amplitude of average volatility was 1.44% (last week), 1.15% (last month), and 1.08% (last quarter).

dividend yield

as maintained by morningstar, inc., the next dividend payment is on nov 8, 2023, the estimated forward annual dividend rate is 0.6 and the estimated forward annual dividend yield is 1.43%.

more news about tff group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com